Arachidonic Acid is a carboxylic or inorganic acid with defined pKₐ value governing its ionisation state across the pH range of biological fluids and pharmaceutical formulations. In pharmaceutical development, Arachidonic Acid serves roles including counter-ion selection for API salt formation, pH adjustment and buffering in liquid formulations, and chemical reagent in API synthesis. Toxicological assessment for PDE derivation evaluates local irritancy effects on gastrointestinal mucosa, skin, and respiratory epithelium alongside systemic metabolic consequences of absorbed quantities, with the most sensitive endpoint in the most relevant study forming the POD.
Genotoxicity data for Arachidonic Acid are assessed under the ICH M7 framework for carcinogenic impurity qualification. A positive Ames test result without a clear non-genotoxic mechanism triggers linear extrapolation from carcinogenicity data, with the acceptable intake derived from the TD50 or the default value of 1.5 µg/day for lifetime exposure
